Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Precision Drilling
PDS
5
New Fortress Energy
NFE
US OptionsDetailed Quotes
VRTX250411C610000
- 0.00
- 0.000.00%
15min DelayClose Apr 17 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest610.00Strike Price0.00Turnover0.00%IV24.72%PremiumApr 11, 2025Expiry Date0.00Intrinsic Value100Multiplier-9DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma--Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Vertex Pharmaceuticals Newsroom
BMO Capital Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Raises Target Price to $557
Peering Into Vertex Pharmaceuticals's Recent Short Interest
Express News | Vertex Pharmaceuticals Inc : BMO Raises Target Price to $557 From $520
Trump's New Order Targets Drug Pricing Transparency And Medicare Cost Reduction
Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Share Price Not Quite Adding Up
Goldman Sachs Adjusts Price Target on Vertex Pharmaceuticals to $617 From $615, Maintains Buy Rating
Uncertainty looms, which biotech stocks in the U.S. are expected to break through? Goldman Sachs provides the answer.
Goldman Sachs suggests focusing on companies that are less affected by tariffs and policy risks, such as Vertex Pharmaceuticals (VRTX.US) and Alnylam Pharmaceuticals (ALNY.US).
BMO Capital Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $545
CrowdStrike, Robinhood, Palo Alto Networks And A Health Care Stock On CNBC's 'Final Trades'
Vertex Researcher, Paul Negulescu Ph.D., Receives the 2025 Canada Gairdner International Award for Pioneering Research and Discovery of Medicines for Cystic Fibrosis
Express News | Vertex Researcher, Paul Negulescu Ph.d., Receives the 2025 Canada Gairdner International Award for Pioneering Research and Discovery of Medicines for Cystic Fibrosis
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
Vertex Pharmaceuticals (VRTX) Stock Moves -1.41%: What You Should Know
Express News | UPDATE: CNBC Halftime Report Final Trades: Vertex Pharmaceuticals, Robinhood Markets, Palo Alto Networks, CrowdStrike Holdings
Analysts Offer Insights on Healthcare Companies: NovoCure (NVCR), Sarepta Therapeutics (SRPT) and Vertex Pharmaceuticals (VRTX)
Morgan Stanley Adjusts PT on Vertex Pharmaceuticals to $462 From $459, Keeps Equalweight Rating
Vertex Pharmaceuticals Price Target Raised to $462 From $459 at Morgan Stanley
An Intrinsic Calculation For Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Suggests It's 41% Undervalued
Is Vertex Pharmaceuticals Incorporated (VRTX) the Best Long Term Growth Stock to Buy According to Billionaires?
These 5 S&P 500 Winners Held Strong In Q1 — Can The Rally Continue?
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now